tacrolimus monohydrate

Poland

Drugs containing this active substance

  • DERMITOPIC

    The ointment is intended for the treatment of moderate to severe forms of atopic dermatitis (eczema) in adults, adolescents, and children over 2 years of age, which have not responded to traditional corticosteroid treatment.

    Form: ointment

    Active substance Dosage
    tacrolimus monohydrate 0.03 % (W/W)

    ATC: D11AH01

    Manufacturer: Bausch Health Poland Sp. z o.o. Laboratori Fundació Dau